HI homepage

Thumbnail

“As I step into the role of president, I look forward to continuing strong advocacy for interventional radiologists and ensuring our members are recognized for the value they provide to the healthcare system and improving patient access to high-quality care."

Heartflow artificial intelligence CCTA images

The Mountain View, California-based company—which creates personalized models of the heart from CT scans—is taking rival Cleerly to court. 

Microbot Medical LIBERTY robotic endovascular system

The system was cleared by the U.S. Food and Drug Administration in September and was adopted by the interventional team at Atlanta-based Emory shortly after.

Thumbnail

Women who underwent mammograms at the facility during the specified timeframe may need to have those exams repeated. 

Thumbnail

The joint venture is intended to advance cancer diagnostics and treatment, with the potential to rake in over $4 billion, those involved estimate.  

I-MED Radiology Network

UPDATED: America’s largest radiology group has purportedly considered making a bid to buy its Australian counterpart, which tallied over $176 million in adjusted earnings last year. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.